Capvizr
News · All summaries
Healthcare & Life Sciences
Fore Biotherapeutics
Pre-Series A$67 million
2 disclosed rounds
RoundPre-Series A
Amount$67 million
LeadPfizer Ventures
DateJuly 7, 2026
THE DEAL, AT A GLANCE

Fore Biotherapeutics

From the announcement
Who is involvedBacked by Pfizer Ventures, 2025-10-02From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedFore Biotherapeutics raised $67M Pre-Series A, announced 2026-07-07From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersFore Biotherapeutics represents a mid-market Healthcare & Life Sciences financing within an active sector tape, with Pfizer Ventures leading a round that sits at the…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Fore Biotherapeutics · Financing Record

Explore source-linked visual explanations for Fore Biotherapeutics. Unsupported claims are withheld while source review continues.

Record 7666 · Recorded date: 2026-07-07

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime